about
The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survivalControversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patientsBufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum StressDihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.Therapeutic effects of matrine on primary and metastatic breast cancer.Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in ratsRepositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents.A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy.Correction: A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy.Bilirubin protects grafts against nonspecific inflammation-induced injury in syngeneic intraportal islet transplantation."Iron-saturated" bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice.Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status.Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer.Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathwaysCarvacrol alleviates ischemia reperfusion injury by regulating the PI3K-Akt pathway in rats.The influence of modified pluronic F127 copolymers with higher phase transition temperature on arsenic trioxide-releasing properties and toxicity in a subcutaneous model of ratsThe role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepatic ischemia/reperfusion injury in miceMiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.Molecular and biotechnological advances in milk proteins in relation to human health.Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1.Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma.Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway.Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway.Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs.STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo.Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo.Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice.Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice.Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer.Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells.Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas.
P50
Q26829844-2B4240F8-C3BF-438D-B088-EE769169E885Q27024123-5D43446E-38AC-439B-9658-43E48797D3E8Q28548246-023B71F7-5242-4C9A-9535-2A21F8F59366Q33408136-9C545802-E9BE-4CE5-99A6-B2524ADADE93Q33742371-29502146-E367-4DD5-B73B-9567906CAE83Q34055831-037FAF1A-7987-4877-BADF-847D299858CCQ34081764-31A3B3EA-EB9C-4400-8C87-D9DCA22E7F77Q34220632-C833D0C8-66DB-4C9B-AA9A-349E50FFCB3CQ34331247-DC397551-69D2-4487-8B5A-8C6EC6B9B32FQ34355811-62330B3C-CCE8-46E2-8BFC-95C07E626CFAQ34508653-29759949-4406-4DB4-BFDB-99C666D5F7B1Q34579802-2F0A9E20-CF68-4317-8CB5-38D8CBE7ACB8Q34964017-B0D65BFC-471E-4508-BA9C-A8CB0ACE4A81Q35133254-A7E8D7DE-1EF8-4F5A-AA76-D05168B8C140Q35217079-D3B6914C-037B-4079-823F-DA7CBDB531BDQ35999080-45ADACDB-3D96-4BF9-A7C6-04591F123E1AQ36187789-F43015EE-7850-488C-BAAE-02A185DD2DA7Q36557155-37A7B549-37AF-4884-9169-A98CB2A2D797Q37581829-8E9AAFFE-4CF9-4D78-8A3B-DA8B0DC67C97Q37640413-F25B23E6-D3FC-4707-A291-C0E2C362BC76Q37926039-C0FFBB34-752F-4AAD-9C44-723B8B154FECQ38848483-97426C2A-86D7-4194-89DB-7DEE84EA1BE0Q38868359-EA94F331-89B5-4DA3-B9F1-B6D6C460889AQ39028255-5ECA6113-CD1A-4B2A-B871-C6C5FA840F57Q39031621-5BF85617-208D-496D-A024-256742185B02Q39166023-5CC5E808-A9F0-49E7-903F-FB1E57724F30Q39208083-40FF5254-C330-47AB-BDBE-D64E0B1D2ED9Q39218247-6081CD39-DF03-4FE1-8E7B-2379488EA0A7Q39228469-777610B5-D4CA-4342-9411-3A97C093ECD8Q39432374-48F9505D-C46A-4FBC-9627-C4527BFA90E3Q39618507-D1AAE36E-FCCE-415C-915F-A830FFBAF246Q39647058-EAB6AA49-6326-43E1-85A1-E0E6555C2841Q39703345-66F19ED8-39C8-4ADF-9371-9CC5E91EF703Q39729578-9583EAB2-B8E5-4583-8A94-E4653C9ABA5EQ39765023-36B3BCC3-A70F-4398-8905-B7BFB2A3B9A1Q39780870-44614100-2A94-4D64-B34C-3E2763CDDB72Q39868168-909C6087-D4E8-4636-8178-1A708A4CA797Q39915185-5555B6C2-53A3-426C-A631-DC234EED46AAQ39994642-5DCE5724-EB72-4035-B7CB-CE0CF92ED43BQ40002803-87D4C1E4-BB33-4981-99F8-5EAD4590EB7E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Xueying Sun
@ast
Xueying Sun
@en
Xueying Sun
@es
Xueying Sun
@nl
Xueying Sun
@sl
type
label
Xueying Sun
@ast
Xueying Sun
@en
Xueying Sun
@es
Xueying Sun
@nl
Xueying Sun
@sl
altLabel
Kevin Sun
@en
prefLabel
Xueying Sun
@ast
Xueying Sun
@en
Xueying Sun
@es
Xueying Sun
@nl
Xueying Sun
@sl
P106
P21
P31
P496
0000-0002-8065-8747